B of A Securities Downgrades Addus HomeCare to Neutral, Lowers Price Target to $125

Benzinga Newsdesk www.benzinga.com Negative 86.9%

Neg 86.9% Neu 0% Pos 0%

B of A Securities analyst Joanna Gajuk downgrades Addus HomeCare (NASDAQ:ADUS) from Buy to Neutral and lowers the price target from $140 to $125.